Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.
2.

Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA.

Silverberg K, Schertz J, Falk B, Beresniak A.

Reprod Biomed Online. 2002 Nov-Dec;5(3):265-9.

PMID:
12470524
3.

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.

Silverberg K, Daya S, Auray JP, Duru G, Ledger W, Wikland M, Bouzayen R, O'Brien M, Falk B, Beresniak A.

Fertil Steril. 2002 Jan;77(1):107-13.

PMID:
11779599
4.

Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: a statistical model-derived analysis.

Gerli S, Bini V, Di Renzo GC.

Gynecol Endocrinol. 2008 Jan;24(1):18-23. doi: 10.1080/09513590701690241.

PMID:
18224540
5.

Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.

Gerli S, Casini ML, Unfer V, Costabile L, Bini V, Di Renzo GC.

Fertil Steril. 2004 Sep;82(3):573-8.

PMID:
15374698
6.

Models of cost-effectiveness of recombinant FSH versus urinary FSH.

Al-Inany H, Afnan M.

Hum Reprod. 2002 Jun;17(6):1671-3; author reply 1673-4. No abstract available. Erratum in: Hum Reprod. 2002 Jul;17(7):1929..

PMID:
12042297
7.

An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial.

Wechowski J, Connolly M, McEwan P, Kennedy R.

Reprod Biomed Online. 2007 Nov;15(5):500-6.

PMID:
18028739
8.
9.

Pharmaco-economic aspects of in-vitro fertilization in Italy.

Mantovani LG, Belisari A, Szucs TD.

Hum Reprod. 1999 Apr;14(4):953-8.

PMID:
10221226
10.

[In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].

de Mouzon J, Allavena E, Schmitt C, Frappé M.

Gynecol Obstet Fertil. 2004 Jun;32(6):508-18. French.

PMID:
15217566
11.
12.

Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system.

Romeu A, Balasch J, Ruiz Balda JA, Barri PN, Daya S, Auray JP, Duru G, Beresniak A, Peinado JA.

J Assist Reprod Genet. 2003 Aug;20(8):294-300.

13.
14.

Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?

Ola B, Afnan M, Sharif K, Hammadieh N, Papaioannou S, Coomarasamy A.

Acta Obstet Gynecol Scand. 2001 Dec;80(12):1141-2. No abstract available.

PMID:
11846714
15.

[Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment].

Poulsen PB, Højgaard A, Quartarolo JP.

Ugeskr Laeger. 2007 Apr 2;169(14):1313-7. Danish.

PMID:
17437694
16.

Costs and outcomes associated with IVF using recombinant FSH.

Ledger W, Wiebinga C, Anderson P, Irwin D, Holman A, Lloyd A.

Reprod Biomed Online. 2009 Sep;19(3):337-42.

PMID:
19778478
17.

[Pharmacoeconomic advantages of recombinant FSH vs urinary derived FSH].

Beresniak A.

Gynecol Obstet Fertil. 2004 Sep;32(9):756-9. French.

PMID:
15380758
18.

Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.

Fiddelers AA, Dirksen CD, Dumoulin JC, van Montfoort AP, Land JA, Janssen JM, Evers JL, Severens JL.

Hum Reprod. 2009 Jul;24(7):1648-55. doi: 10.1093/humrep/dep041. Epub 2009 Mar 24.

PMID:
19318703
19.

Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.

Fragoulakis V, Pescott CP, Smeenk JM, van Santbrink EJ, Oosterhuis GJ, Broekmans FJ, Maniadakis N.

Appl Health Econ Health Policy. 2016 Dec;14(6):719-727.

PMID:
27581117
20.

Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.

Bedaiwy MA, Forman R, Mousa NA, Al Inany HG, Casper RF.

Hum Reprod. 2006 Nov;21(11):2838-44. Epub 2006 Jul 27.

PMID:
16877370

Supplemental Content

Support Center